InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Oboyle Kevin C, 董事. Officer active across 5 companies, notably NEVRO CORP. In total, 13 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €74k. History available since 25 May 2021. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Oboyle Kevin C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
13,698 股0Common StockSEC:0001193125-26-276633:0
17,333 股0Common StockSEC:0000950170-25-098533:0
2,035 股0Common StockSEC:0001388658-25-000184:0
8,983 股0Common StockSEC:0001484612-25-000057:0
15,135 股0Common StockSEC:0001484612-25-000040:0
43,396 股Common StockSEC:0000950170-25-050464:0
19,169 股0Common StockSEC:0001610717-24-000264:0
6,754 股0Common StockSEC:0001610717-23-000078:0
103,306 股0Common StockSEC:0001209191-22-036505:0
4,155 股0Common StockSEC:0001567619-22-011888:0
1,000 股@ US$83.75100.0% 占其流量Common StockSEC:0001567619-21-022198:0
标准退出：2022年3月14日 (T+90)
16,870 股0Common StockSEC:0001209191-21-040774:0
1,167 股0Common StockSEC:0001567619-21-011222:0
13 条申报中的 13 条
About Oboyle Kevin C
Kevin C. O'Boyle is a Director at NEVRO CORP, CARLSMED, INC., Outset Medical, Inc., Sientra, Inc. and iRhythm Technologies, Inc. He has 13 filings in total, all in the sampled set, with EUR 74,211 of buys and EUR 0 of sells, over the period from 2021-05-26 to 2026-06-22. The modal transaction nature is Attribution.
